"Chesapeake Urology is the largest, fully-integrated urology practice in Maryland and the Mid-Atlantic region, providing a comprehensive array of urologic services to patients. Our staff of more than 800 professionals, including more than 80 urologists and fellowship-trained specialists, focus on what’s most important to patients – superior and personalized care, an innovative approach to the most advanced diagnostics, leading-edge treatments, and clinical trials, as well as positive outcomes. At Chesapeake Urology, we’re dedicated to providing the most personal care for life’s most personal issues."

During the past decade, Chesapeake Urology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chesapeake Urology" #1 sponsor was "Solace Therapeutics, Inc." with 3 trials, followed by "Allergan" with 2 trials sponsored, "ASTORA Women's Health" with 1 trials sponsored, "Spinal Singularity" with 1 trials sponsored and "Valencia Technologies Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Chesapeake Urology" are "Stress Urinary Incontinence" (3 trials), "Urinary Incontinence" (2 trials), "Incontinence, Urinary" (1 trials), "Neurogenic Bladder" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "Chesapeake Urology" in a lesser frequency.

Most popular intervention types in "Chesapeake Urology" are "Device" (6 trials), "Drug" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vesair Balloon" (2 trials), "Connected Urinary Catheter" (1 trials), "Elevate Anterior and Apical" (1 trials), "Native Tissue Repair for pelvic organ prolapse" (1 trials) and "OnabotulinumtoxinA and Hydrogel admixture" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chesapeake Urology" are 4 trials for "Female" genders, 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Chesapeake Urology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Chesapeake Urology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Chesapeake Urology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".